You’ve started semaglutide or liraglutide, and finally, finally, the scale is moving in the direction you’ve been waiting on for ages. That’s a wonderful place to be in, so first off, well done. Here’s the inconvenient bit nobody really tells you, though. Your scale is, frankly speaking, lying to you a little. It can only see one number and has absolutely no clue whether what you’re losing is fat, lean tissue, bone, or some odd cocktail of all three. And on a GLP-1 medication? That detail isn’t a small one.
This is exactly the gap that a DEXA scan, short for Dual-Energy X-ray Absorptiometry, was made to fill. Think of it as the second opinion your bathroom scale really should be paying for. It cuts through the surface number and shows you the actual breakdown of what’s coming off your body — fat, muscle, or bone — which sounds technical but actually has a real-world impact on how you’ll look, move, and feel a year from now. And by the way, multiple published trials have already shown that a meaningful chunk of the weight people drop on GLP-1 therapy isn’t fat at all.
Now, we’ve actually written about why exercise during GLP-1 weight loss is non-negotiable for protecting your bones over in our piece on GLP-1 and bone health. So consider this article the practical sibling to that one. We’ll go through, step by step, how to actually use a DEXA scan to keep tabs on what’s happening, what the latest science is saying about your muscles and your bones, and which conversations you really should be opening with your doctor in between scans.
Just one quick thing before we go in: this article is purely for general information, not medical advice. So when it comes to anything around how often you scan, what dose of medication you’re on, or which exercises you should be doing, your treating clinician should always be the final word on that — not Google, and definitely not us.
1. Get a Baseline Scan Before You Even Start
If there’s one DEXA scan that ends up paying for itself in clarity, it’s the one you do before you even take your first GLP-1 dose. Why is that? Because a baseline gives your physician three numbers your bathroom scale will simply never tell you.
The three numbers your scale can’t see
Specifically, your total lean (or fat-free) mass in kilograms. Your total fat mass, both as a kilogram figure and as a percentage of your body weight. And finally, your bone mineral density (BMD) at the spine, hip, and the forearm in some scanners.
Why a starting point matters
Without a starting point, every scan that comes afterwards is a bit harder to read. Suppose you walk into a follow-up at month six and see your lean mass has dropped — well, that number really only tells a story when you can compare it back to where you were on day one, right? So if there’s any way to fit a baseline scan in before your very first injection, please make the time.
2. Build a Scan Schedule That Actually Makes Sense
As of now, there isn’t one official guideline that lays out exactly how often you should be repeating a DEXA while you’re on GLP-1 therapy. That said, depending on how rapidly the weight is coming off, here’s a sensible rhythm to keep in mind.
A reasonable scan cadence
Start with that baseline scan we’ve already talked about, before treatment kicks off. Then a follow-up around three to six months in, once your weight loss has plateaued at the maintenance dose; that timing usually works well for most patients. From there, an annual body-composition scan is reasonable as long as you’re staying on therapy. Bone-density scans, however, can be spaced a bit further apart, around every two years; though if you’re over 50, post-menopausal, on long-term GLP-1 therapy with rapid weight loss, or have other osteoporosis risk factors stacked up, you’ll want to bring those forward.
What about the radiation?
If the radiation aspect of all of this is making you a little nervous, take a deep breath, because honestly it really shouldn’t. DEXA is a low-radiation exam by every reasonable standard. A whole-body composition scan, in fact, gives you around 4 to 5 microsieverts (µSv) of effective dose. To make that mean something, a single transcontinental flight from New York to Los Angeles will already expose you to about 35 to 40 µSv from cosmic radiation. So you’re roughly at one-tenth of a single flight per scan, which is a dose well within the range that radiology bodies consider clinically negligible, even with repeated use.
3. Track Muscle, Not Just the Number on the Scale
What the STEP-1 trial actually showed
The cleanest body-composition data we currently have on GLP-1s comes out of the STEP-1 trial, the once-weekly semaglutide 2.4 mg study that Wilding and colleagues published in NEJM back in 2021. Inside that trial they ran a DEXA sub-study, following 140 participants over a 68-week stretch, and what came out is honestly worth thinking about.
In the semaglutide arm, total fat mass went down by 10.40 kg, while in the placebo arm, the drop was only 1.17 kg, which works out to a treatment difference of nearly 9 kg of pure body fat. Now, total lean mass also went down, but in both groups; on semaglutide it came down by 6.92 kg, and on placebo by 1.48 kg. Here’s the catch though, since the fat loss outpaced the lean loss, the proportion of lean tissue actually went up, by 3.6 percentage points in the semaglutide arm and a tiny 0.1 percentage points in the placebo arm.
So what does this mean for you?
A couple of things really, and they’re both worth sitting with.
For starters, the lean-mass loss on a GLP-1 is a real phenomenon, and yes, it’s noticeably bigger than what you’d see on placebo. A 5 to 7 kg drop in skeletal muscle over a single year is enough to nudge your strength, your gait stability, and your resting metabolic rate. Now here’s the part nobody really enjoys hearing — once that muscle is gone, getting it back tends to be far more work than losing fat ever was.
The fat-to-lean ratio still ends up better
At the same time, the ratio of fat to lean tissue still ends up better than where it started. So no, GLP-1 therapy isn’t really wasting your muscle in any clinical sense of the word. It’s shrinking your whole body, and lean tissue, like everything else, shrinks along with it. The question worth genuinely asking is whether the lean loss is more than what’d typically be expected for that amount of weight, and if it can be blunted with extra protein and some resistance training. DEXA, frankly, is the clearest way to get a personal answer to that.
4. Watch Your Bone Density, Especially With Rapid Weight Loss
What the Jensen trial found
The data on GLP-1s and bone is admittedly still a bit messy, but a clearer picture is starting to come into focus. Take Jensen et al., for example, who published in JAMA Network Open in 2024 — a randomized trial running 195 adults with obesity through a one-year intervention right after they completed an 8-week low-calorie diet.
What the team observed is, well, kind of telling. Liraglutide on its own ended up reducing BMD at the hip and spine more than exercise on its own did, even though the two groups lost about the same amount of weight. Exercise alone? It actually preserved BMD at both the hip and the spine. And the combination, exercise plus liraglutide, showed no significant BMD change versus placebo, which is honestly the result you’d be hoping for.
The takeaway is a little counterintuitive
So the takeaway here is interesting and a little counterintuitive at first. Most of the bone signal seems to be coming from the weight loss itself, rather than from GLP-1 medications specifically; and structured exercise during weight loss is the thing that ends up protecting your bones. This actually slots in pretty neatly with older research on bone loss after bariatric surgery, and after long stretches of severe caloric restriction, so it’s not really a fresh finding.
What this means for your follow-ups
What this means in practice is fairly simple. Your follow-up DEXA scans during GLP-1 therapy ought to track BMD at the lumbar spine and total hip, alongside body composition. And resistance and weight-bearing exercise really ought to come up at every single appointment with your doctor, not just the very first one.
5. Actually Change Something Based on the Results
A DEXA scan is only as useful as the decisions it’s leading to. Otherwise, you’re just collecting numbers in a file. So here’s where the scan can actually start changing what you do next.
Protein intake
Take protein intake, for instance. If your muscle is dropping faster than what you’d expect, the standard advice is to nudge protein up to roughly 1.2 to 1.6 grams per kilogram of target body weight per day, while keeping a watchful eye on kidney function. A registered dietitian, or just your doctor, can take that range and turn it into actual meals you’d want to eat in real life, rather than scary numbers on a sheet.
Resistance training
Then there’s resistance training. If you’re seeing your lean mass or your BMD going downhill, the single highest-yield change you can make? It’s adding two to three sessions of progressive resistance training to your weekly schedule. Note that bit — not piling on more cardio. Resistance training is what’s been shown to do the heavy lifting in this scenario, no pun intended.
Dose pacing
Dose pacing is another piece worth talking about. Some clinicians actually slow GLP-1 dose escalation right down, or hold off on dose increases altogether, when a DEXA shows aggressive lean or bone loss creeping in. Any dose decision really should sit with your prescribing physician, mind you, not be made off your own back from a scan report alone.
Adjunctive therapy
And there’s also adjunctive therapy. For higher-risk patients, things like older adults, post-menopausal women, anyone with diagnosed osteoporosis, clinicians will sometimes look into additional interventions specifically focused on bone protection. This bit is really individualized, and it’s not something to attempt without proper medical guidance behind you.
The bigger picture
To be clear about it, a DEXA scan doesn’t take the place of your scale, your lab panel, or actual conversations with your doctor. What it does is layer some objectivity over the top of a treatment that’s making pretty large, pretty fast changes inside your body. It hands both of you, you and your physician, a shared map of what’s actually unfolding under the surface of your weight loss, which is genuinely useful when you’re trying to make decisions together.
Wrapping Up
GLP-1 medications work, seriously well, for weight loss, and that’s worth being a little bit happy about. But the weight that comes off isn’t all fat. There’s lean tissue mixed in, and in some patients, even a slice of bone too. A baseline DEXA scan plus a few periodic follow-ups, paired with enough protein on your plate and regular resistance training, can take “I lost 15 kg” and turn it into “I lost 10 kg of fat, hung onto most of my muscle, and held my spine BMD steady.” Clinically speaking, that’s a meaningfully better outcome — and frankly, it’s the kind of result you really want to walk away with after putting in the work on your weight loss journey.
References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med 2021;384(11):989–1002. https://www.nejm.org/doi/full/10.1056/NEJMoa2032183 (DEXA sub-study results in Supplementary Appendix Table S5).
- Jensen SBK, Sørensen V, Sandsdal RM, et al. Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open 2024;7(6):e2416775. https://pmc.ncbi.nlm.nih.gov/articles/PMC11200146/
- Shepherd JA, Ng BK, Sommer MJ, Heymsfield SB. Body composition by DXA. Bone 2017;104:101–105. https://pmc.ncbi.nlm.nih.gov/articles/PMC5659281/
- International Atomic Energy Agency. Radiation protection of patients during DXA bone densitometry. https://www.iaea.org/resources/rpop/health-professionals/other-specialities-and-imaging-modalities/dxa-bone-mineral-densitometry/patients
- UCLA Health. Rapid weight loss can lead to loss of muscle mass. https://www.uclahealth.org/news/article/rapid-weight-loss-can-lead-loss-muscle-mass